Search

Author/Creator Yang, Jingke

1. Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report. Issue 1 (January 2017)

Authors:
Zuo, Wenli; Zhu, Xinghu; Yang, Jingke; Mei, Zhenyang; Deng, Mei; Lin, Quande; Song, Yongping; Yin, Qingsong
Editors:
Liu., Yong
Journal:
Medicine
Issue:
Volume 96:Issue 1(2016)
Page Start:
e5787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma: A case report. Issue 1 (January 2017)

Authors:
Zuo, Wenli; Zhu, Xinghu; Yang, Jingke; Mei, Zhenyang; Deng, Mei; Lin, Quande; Song, Yongping; Yin, Qingsong
Other Names:
Liu. Yong section editor.
Journal:
Medicine
Issue:
Volume 96:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway. (18th May 2016)

Authors:
Han, Li; Guo, Xiaojuan; Bian, Hua; Yang, Lei; Chen, Zhong; Zang, Wenhua; Yang, Jingke
Other Names:
Kim Youn C. Academic Editor.
Journal:
Evidence-based complementary and alternative medicine
Issue:
Volume 2016(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗